+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematological Drugs Market Research Reports

From
Cold Agglutinin Disease (CAD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cold Agglutinin Disease (CAD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Immune Thrombocytopenia (ITP) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Immune Thrombocytopenia (ITP) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Essential Thrombocythemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Essential Thrombocythemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Beta-thalassemia (B-thal) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Beta-thalassemia (B-thal) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Von Willebrand Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Von Willebrand Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Iron Deficiency Anemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Iron Deficiency Anemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hemophilia B - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hemophilia B - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
US Thrombotic Thrombocytopenic Purpura (TTP) - Epidemiology Forecast to 2030 - Product Thumbnail Image

US Thrombotic Thrombocytopenic Purpura (TTP) - Epidemiology Forecast to 2030

  • Drug Pipelines
  • October 2021
  • 50 Pages
  • United States
From
From
From
Hemlibra - Drug Insight, 2019 - Product Thumbnail Image

Hemlibra - Drug Insight, 2019

  • Report
  • July 2019
  • Global
From
From
From
From
From
From
Loading Indicator

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders. The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more